Botswana: PrEP trial will be unable to show if drugs block infection

A trial of pre-exposure prophylaxis to prevent HIV infection in Botswana is highly unlikely to show whether giving antiretroviral drugs to block infection is effective, due to a lower-than-expected rate of new infections and low retention rates, the US Centers for Disease Control announced on December 17th.